Ifenec 1% Econazole Nitrate Antifungal Dermal Powder 30g

NAME
IFENEC

PHARMACOTHERAPEUTIC CATEGORY
Topical antifungals.

ACTIVE PRINCIPLES
Econazole nitrate.

EXCIPIENTS
Cream: polyoxyethylene glycol palmite stearate; polyoxyethylenated glycerides of saturated fatty acids; liquid paraffin; benzoic acid; butylated hydroxyanisole; purified water. Skin emulsion: polyoxyethylene glycol palmito stearate; polyoxyethylenated glycerides of saturated fatty acids; liquid paraffin; precipitated silica; benzoic acid; butylated hydroxyanisole; purified water. Skin powder: zinc oxide; precipitated silica; talc. Skin solution: polysorbate 20; benzyl alcohol; sorbitanmonolaurate; water-sodium tridecyl ether sulfate-sodium lauroampoacetate, sodium salt, polyethylene glycol 6000 distearate; purified water.

INDICATIONS
Cream, skin powder, skin emulsion: fungal infections of the skin and its appendages, even if complicated by germigram-positive superinfections. Skin solution: pityriasis versicolor.

CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'individual already' established towards the components.

DOSAGE
Cream, skin emulsion, skin powder: spread the cream on the lesion twice a day (use the drug emulsion on the hair and hair areas). In the treatment of onychomycosis, cover with occlusive dressing. Use the skin powder in wet infections, interdigital mycosis and for the daily disinfection of socks and the inside of shoes. Skin solution: the product must be used, for at least three consecutive evenings, as a bath solution by sprinkling the whole body, previously wet, with a sponge on which the contents of a medicine sachet have been poured. Rub for a few minutes (3-5) then let the solution dry without rinsing: a shower with water only the following morning is allowed; in this way the drug has the possibility to carry out its action on the entire body surface for the whole night. If after 15 days from the end of the therapy the Pityriasis versicolor is still not eradicated, it is advisable to repeat a second course of treatment. In any case, in order to avoid relapses or reinfections, it is recommended to repeat the treatment after 1-3 months.

STORAGE
None.

WARNINGS
All pharmaceutical forms of the product are indicated for external use only.

INTERACTIONS
None known.

SIDE EFFECTS
The drug is generally well tolerated even by sensitive skin. Only in very rare cases are local irritation possible in eczematous areas: in such situations, for a few days, the therapy with the medicine should be preceded by an anti-eczematous treatment.

PREGNANCY AND BREASTFEEDING
In pregnant women and in very early childhood, the product should be administered in cases of real need. Preparations for topical use, especially if used for prolonged treatments, can give rise to sensitization phenomena. If this happens it is necessary to interrupt the treatment and institute a suitable therapy.